Mindray Medical (MR) Reports Mixed Q1 Results
Mindray Medical (NYSE: MR) reports Q1 EPS of $0.27, 2 cents better than the analyst estimate of $0.25. Revenue for the quarter was $134.2 million, versus the consensus of $144.89 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
